Sphere Fluidics announces enhanced Cyto-Mine capability and performance
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced it has enhanced
Read more
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses
Read more
Study provides new insight on how HER2-low tumors may evolve in breast cancer patients
The finding that breast tumors can evolve to express low HER2 potentially widens the number of patients who can benefit
Read more
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody
Read more
Recovered COVID-19 patients may need only a single vaccine dose, suggests study
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune
Read more
Eli Lilly to focus on selling COVID-19 antibody drug combination
FILE PHOTO: A sign is pictured outside an Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in
Read more
Researchers identify several novel SARS-CoV-2 inhibitors
Researchers in London, UK, have identified several compounds with SARS-CoV-2 inhibiting properties, that potentially may be developed into antiviral solutions
Read more
COVID vaccination earlier in pregnancy leads to better antibody transfer to baby
Women who were vaccinated for COVID-19 earlier in their third trimester had a higher likelihood of passing protective antibodies to
Read more
Risk of SARS-CoV-2 from reinfected individuals with previous infection or vaccination
A technical report recently published by the European Center for Disease Prevention and Control (ECDC) has summarized all available literature
Read more
One dose of Pfizer vaccine generates strong immune response against COVID-19
A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC)
Read more